We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

More on Multiple Sclerosis and Neuromyelitis Optica

Diego Franciotta, MD; Sven Jarius, MD; Francesca Aloisi, BS
Arch Neurol. 2007;64(12):1802. doi:10.1001/archneur.64.12.1802-a.
Text Size: A A A
Published online


In an interesting article from the series “Controversies in Neurology,” different points of view address the topic of whether multiple sclerosis (MS) and neuromyelitis optica (NMO) are distinct diseases or parts of a unique nosological spectrum.1,2 These views should be considered in the light of the following, additional points. First, oligoclonal bands, a hallmark of MS, tend to disappear over time when present in the cerebrospinal fluid of patients with NMO.3 Second, an intrathecal, polyspecific immune response to measles, rubella, and zoster virus (MRZ reaction) is detectable in about 80% of patients with MS but rarely in NMO (1 of 20 patients in our series)4 and helps in differential diagnosis. Third, titers of anti–Epstein-Barr virus nuclear antigen antibodies in patients with MS are higher than in controls5 and in NMO patients with NMO (mean [SEM] values: 13.5 [1.4] DU/mL, n = 16 for NMO; 18.9 [1.0], n = 23 for MS; 11.6 [1.5], n = 37 for blood donors; P < .002, MS vs NMO/blood donors; D. Franciotta, MD; S. Jarius, MD; 2007, unpublished data). Fourth, new recombinant assays for anti-aquaporin-4 antibodies can increase diagnostic sensitivity (91%6) and specificity (98.6%7-100%6) for NMO, reinforcing their role as robust disease markers.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles